Celestial Biolabs Ltd.
NSE: CELESTIAL | BSE: 532871
₹1.75
₹-0.05
(-2.78%)
As on 11-Mar-2020IST
Market cap
₹5 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-19 %
-
ROCE
-3.9 %
-
Industry P/E
39.9
-
EV/EBITDA
1.4
-
Debt to Equity
4.3
-
Book Value
₹--
-
EPS
₹-0.2
-
Face value
10
-
Shares outstanding
22,586,350
10 Years Aggregate
CFO
₹46.74 Cr
EBITDA
₹-37.84 Cr
Net Profit
₹-88.52 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Celestial Biolabs
| -34.0 | -30.0 | -45.3 | -71.5 | -58.8 | -51.9 | -25.7 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|---|---|
|
Celestial Biolabs
| -69.5 | -60.8 | 3.4 | -44.9 | -10.9 | 130.2 |
|
BSE Sensex
| 14.4 | 5.9 | 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -3.5 | -5.9 | 0.5 | -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Celestial Biolabs
|
1.8 | 4.6 | 0.1 | -0.4 | -303.0 | -15 | -- | 0.0 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Celestial Biolabs
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1997
-
Chairman
--
-
Managing Director
Amit Kumar Singh
-
Headquarters
Medchal, Telangana
-
Website
Looking for more details about Celestial Biolabs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Celestial Biolabs
What is the current share price of Celestial Biolabs Ltd Today?
The share price of Celestial Biolabs Ltd is ₹1.75 (NSE) and ₹2.02 (BSE) as of 11-Mar-2020 IST. Celestial Biolabs Ltd has given a return of -58.84% in the last 3 years.
What is the current PB & PE ratio of Celestial Biolabs Ltd?
Since, TTM earnings of Celestial Biolabs Ltd is negative, P/E ratio is not available.
The P/B ratio of Celestial Biolabs Ltd is 0.05 times as on 11-Mar-2020, a 99 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
2020 |
0.00 |
1.16 |
2019 |
0.00 |
0.13 |
What is the 52 Week High and Low of Celestial Biolabs Ltd?
The 52-week high and low of Celestial Biolabs Ltd are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of Celestial Biolabs Ltd?
Celestial Biolabs Ltd has a market capitalisation of ₹ 5 Cr as on 11-Mar-2020. As per SEBI classification, it is a company.
Should I invest in Celestial Biolabs Ltd?
Before investing in Celestial Biolabs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.